Antigenic comparison of bovine type C virus with murine and feline leukemia viruses
Ferrer, J.F.
Cancer Research 32(9): 1871-1877
1972
ISSN/ISBN: 0008-5472 PMID: 4345040 Document Number: 54548
Results of both immunofluorescence and immunodiffusion studies indicate that the type C virus of the NBC-cell lines is an indigenous bovine virus which is antigenically unrelated to the known mammalian type C viruses. Leucosis in cattle and perhaps in other species may be caused by a family of type C viruses different from that of the known leucosis viruses.
Document emailed within 1 workday
Related Documents
Lutz, H.; Lehmann, R.; Winkler, G.; Kottwitz, B.; Dittmer, A.; Wolfensberger, C.; Arnold, P. 1990: Feline immunodeficiency virus in Switzerland: clinical aspects and epidemiology in comparison with feline leukemia virus and coronaviruses Schweizer Archiv für Tierheilkunde 132(5): 217-225Jarrett, O.; Pacitti, A.M.; Hosie, M.J.; Reid, G. 1991: Comparison of diagnostic methods for feline leukemia virus and feline immunodeficiency virus Journal of the American Veterinary Medical Association 199(10): 1362-1364
Jirjis, F.F.; Davis, T.; Lane, J.; Carritt, K.; Sweeney, D.; Williams, J.; Wasmoen, T. 2010: Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine Veterinary Therapeutics: Research in Applied Veterinary Medicine 11(2): E1-E6
Briggs, M.B.; Ott, R.L. 1986: Feline leukemia virus infection in a captive cheetah and the clinical and antibody response of six captive cheetahs to vaccination with a subunit feline leukemia virus vaccine Journal of the American Veterinary Medical Association 189(9): 1197-1199
Cherney, T.M.; Schultz, R.D. 1996: Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes American Journal of Veterinary Research 57(6): 812-818
Baird, S.M. 1979: Antigenic properties and molecular weights of murine leukemia virus-binding proteins Journal of Immunology 122(4): 1389-1396
1991: Panel report on the colloquium on feline leukemia virus/feline immunodeficiency virus: tests and vaccination Journal of the American Veterinary Medical Association 199(10): 1273-1277
Azocar, J.; Essex, M. 1979: Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus Journal of the National Cancer Institute 63(5): 1179-1184
Legendre, A.M.; Hawks, D.M.; Sebring, R.; Rohrbach, B.; Chavez, L.; Chu, H.J.; Acree, W.M. 1991: Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure Journal of the American Veterinary Medical Association 199(10): 1456-1462
Grant, C.K.; Ernisse, B.J.; Pontefract, R. 1984: Comparison of feline leukemia virus-infected and normal cat T-cell lines in interleukin 2-conditioned medium Cancer Research 44(2): 498-502
Olsen, R.G.; Lafrado, L.J.; Lewis, M.G.; Mathes, L.E.; Haffer, K.; Sharpee, R. 1987: Feline leukemia virus current status of the feline acquired immune deficiency syndrome and immunoprevention Wormser, G P (Ed ) Aids, Acquired Immune Deficiency Syndrome, And Other Manifestations Of Hiv Infection: Epidemiology, Etiology, Immunology, Clinical Manifestations, Pathology, Control, Treatment And Prevention Xliii+1103p Noyes Publications: Park Ridge, New Jersey, Usa Illus 160-185
Rojko, J.L.; Fulton, R.M.; Rezanka, L.J.; Williams, L.L.; Copelan, E.; Cheney, C.M.; Reichel, G.S.; Neil, J.C.; Mathes, L.E.; Fisher, T.G. 1992: Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells Laboratory Investigation; a Journal of Technical Methods and Pathology 66(4): 418-426
Grant, C.K.; Essex, M.; Pedersen, N.C.; Hardy, W.D.; Stephenson, J.R.; Cotter, S.M.; Theilen, G.H. 1978: Lysis of feline lymphoma cells by complement-dependent antibodies in feline leukemia virus contact cats. Correlation of lysis and antibodies to feline oncornavirus-associated cell membrane antigen Journal of the National Cancer Institute 60(1): 161-166
Hoss, H.E.; Olson, C. 1974: Infectivity of bovine C- type (leukemia) virus for sheep and goats American Journal of Veterinary Research 35(5): 633-637
Miller, J.M.; Schmerr, M.J.; Van Der Maaten, M.J. 1981: Comparison of four serologic tests for the detection of antibodies to bovine leukemia virus American Journal of Veterinary Research 42(1): 5-8
Gillespie, J.H.; Schlafer, D.H.; Foote, R.H.; Quick, S.; Dougherty, E.; Schiff, E.; Allen, S. 1990: Comparison of persistence of seven bovine viruses on bovine embryos following in vitro exposure Deutsche Tierärztliche Wochenschrift 97(2): 65-68
Greenberger, J.S. 1979: Phenotypically distinct target cells for murine sarcoma virus and murine leukemia virus marrow transformation in vitro Journal of the National Cancer Institute 62(2): 337-348
Onyekaba, C.; Fahrmann, J.; Bueon, L.; King, P.; Goyal, S.M. 1987: Comparison of five cell lines for the propagation of bovine viral diarrhea and infectious bovine rhinotracheitis viruses Microbiologica 10(3): 311-315
Rice, J.B.; Olsen, R.G. 1981: Feline oncovirus-associated cell membrane antigen and feline leukemia virus group-specific antigen expression in bone marrow and serum Journal of the National Cancer Institute 66(4): 737-743
de Noronha, F.; Grant, C.K.; Lutz, H.; Keyes, A.; Rowston, W. 1983: Circulating levels of feline leukemia and sarcoma viruses and fibrosarcoma regression in persistently viremic cats Cancer Research 43(4): 1663-1668